Galecto Inc (GLTO) Stock

DelistedNasdaq: GLTODamora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

24.45
Final close · May 11, 2026

GLTO is no longer traded. Galecto Inc was delisted from the Nasdaq in May 2026.

Prices on this page are historical; the last trade was May 11, 2026 at $24.45.

Galecto Inc stock price history

Split-adjusted closes, 2020–2026

GLTO final trading statistics

Final close
$24.45
Final trading day
May 11, 2026
Market cap at delisting
$1.47B
Shares outstanding
60.24M
Final 52-week range
$2.45 – $38.33
Avg. volume (final 3 mo.)
338,975
All-time high (split-adj.)
$421.00 · Nov 2020
All-time low (split-adj.)
$2.22 · Apr 2025
Return since IPO
-93.5%
Beta
1.57
Book value / share
$5.02
Price / book
4.87
Final 52 wk
2.4538.33

Galecto Inc earnings per share

Earnings per share

Galecto Inc revenue & net income

RevenueNet income

Galecto Inc annual financials

Galecto Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$0.00-$209.8M—
FY2024$0.00-$21.4M-$18.39
FY2023$0.00-$38.3M-$15.99
FY2022$0.00-$61.6M-$44.67
FY2021$0.00-$51.8M-$51.25

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Galecto Inc

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

Galecto Inc stock FAQ

What happened to Galecto Inc stock?

Galecto Inc stock was delisted from the Nasdaq. Its final close was $24.45 on May 11, 2026.

Is GLTO stock still trading?

No. GLTO was delisted from the Nasdaq in May 2026 and no longer trades on a U.S. exchange.

What was the last price of GLTO stock?

GLTO closed at $24.45 on its final trading day, May 11, 2026, for a market value of about $1.47B.

What were Galecto Inc's revenue and earnings in its last full fiscal year?

Galecto Inc reported revenue of $0.00 and net income of -$209.8M in fiscal 2025, its last full year as a public company.

When did Galecto Inc go public?

Galecto Inc stock began trading on October 29, 2020.

Biotechnology stocks to research

All Healthcare stocks →